Parkinson’s disease (PD) is characterized by degeneration of dopaminergic neurons in the basal ganglia, which may be visualized by single photon emission computed tomography (SPECT) in combination with the cocaine analog methyl-3-β-(4-β[123I]iodophenyl)tropane-2β-carboxylate ([123I]β-CIT). The aim of our study was to correlate findings of SPECT with clinical data of 34 previously untreated, idiopathic parkinsonian patients [age: 59.58±10.03 (mean±SD) years; Hoehn and Yahr Scale (HYS) mean range: 1.97±0.83, ranges I–III; Unified PD Rating Scale 3.0 (UPDRS, 30.64±18.68) and 15 healthy controls (age 47.93±10.47 years). SPECT scans were performed with a single-head γ-camera 24 h after intravenous injection of [123I]β-CIT. Comparison of the striatum/cerebellum (S/C) ratio of [123I]β-CIT uptake of controls and parkinsonian subjects, subdivided according to their HYS range, was significant. No influence of age or sex was observed. Significant correlations were found between scores of the HYS, UPDRS parts I–III, part II, part III, and the S/C ratio of [123I]β-CIT uptake. Moreover, SPECT with the radiotracer [123I]β-CIT revealed side-to-side differences in parkinsonian patients and significant associations to contralateral clinical extrapyramidal symptomatology. Our data show that SPECT with [123I]β-CIT is a valuable tool for estimating disease severity in PD.

Keywords:
Parkinson’s disease, [123I]β-CIT SPECT, Presynaptic dopaminergic degeneration
This content is only available via PDF.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.